EUVIMEDOpdag EUVIMED
Crossref

Matriptase‐mediated PAR 2 activation drives monocyte‐to‐macrophage differentiation and polarization under hypoxic conditions

Arpana Singh, Avinandan Bhoumick, Prosenjit Sen iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70046 ↗

At a glance

Journal article in The FEBS Journal, 2025. Written by Arpana Singh and 2 co-authors. Institution: Abramson Cancer Center and Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Major MEDLINE topics: Macrophages, Serine Endopeptidases, Monocytes, Receptor, PAR-2. Cited 3 times so far (Crossref); 49 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Within the intricate landscape of the tumour microenvironment (TME), hypoxia stands out as a pivotal factor profoundly shaping immune cell dynamics. Our study delves into this dynamic interplay, uncovering a cascade of events triggered by hypoxia. We unveil the emergence of protease‐activated receptor 2 (PAR2; also known as F2R‐like trypsin receptor 1 [ F2RL1 ]) expression in monocyte cell lines (THP1) and peripheral blood mononuclear cells (PBMCs), orchestrated by the active serine protease matriptase (TMPRSS2; also known as transmembrane protease serine 2). Hypoxic conditions set the stage for a dual mechanism: lactate accumulation drives extracellular pH reduction, and facilitates matriptase activation from its latent form. A 10 m m lactate threshold activates matriptase, which in turn activates PAR2, driving monocytes towards M1 macrophage differentiation through the AKT2‐NF‐κβ axis. This triggers miR155 expression, which suppresses cytokine signaling 1 (SOCS1), a key regulator of M1–M2 polarisation, while NF‐κβ enhances proinflammatory responses. Notably, our study reveals a temporal switch in this hypoxia‐driven process. After 48 h of hypoxia, lactate levels rise to 25 m m , suppressing matriptase activation and driving a shift towards M2 polarisation. This transition, marked by reduced miR155 expression via AKT2‐NFκβ axis inactivation, highlights the dynamic nature of macrophage polarisation. Our findings demonstrate matriptase as a key regulator driving macrophage polarisation towards the M1 phenotype within hypoxic microenvironments. This insight into macrophage behaviour under hypoxia suggests new strategies for immune modulation to counter tumour progression.

Subjects

MeSH terms (MEDLINE)

MacrophagesSerine EndopeptidasesMonocytesReceptor, PAR-2Cell DifferentiationHumansCell HypoxiaNF-kappa BMicroRNAsTHP-1 CellsSignal TransductionCell PolarityTumor MicroenvironmentProto-Oncogene Proteins c-aktLeukocytes, MononuclearLactic Acid

Author keywords

M1 M2 polarisationPAR2differentiationmacrophagematriptase

Substances

Serine EndopeptidasesReceptor, PAR-2F2RL1 protein, humanmatriptaseNF-kappa BMicroRNAsProto-Oncogene Proteins c-aktLactic Acid

Authors and institutions

  • Abramson Cancer Center and Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India.

ORCID profiles: Prosenjit Sen

Cite

APA

Singh, A., Bhoumick, A., & Sen, P. (2025). Matriptase‐mediated PAR 2 activation drives monocyte‐to‐macrophage differentiation and polarization under hypoxic conditions. The FEBS Journal. https://doi.org/10.1111/febs.70046

Vancouver

Singh A, Bhoumick A, Sen P. Matriptase‐mediated PAR 2 activation drives monocyte‐to‐macrophage differentiation and polarization under hypoxic conditions. The FEBS Journal. 2025. doi:10.1111/febs.70046

BibTeX
@article{Singh2025,
  author = {Singh, Arpana and Bhoumick, Avinandan and Sen, Prosenjit},
  title = {Matriptase‐mediated PAR 2 activation drives monocyte‐to‐macrophage differentiation and polarization under hypoxic conditions},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70046}
}
Start for free →